Chemical Structure (Image 1)
Risedronate Sodium Tablet, Film Coated
Product Images NDC 0093-3099
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Risedronate Sodium (NDC 0093-3099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton 1 Of 2 (Image 10)
Once-a-Week Risedronate Sodium Tablets, USP are available in a 4-week supply with 4 tablets per bottle.*
Figure 1 (Image 2)
Figure 2 (Image 3)
Figure 3 (Image 4)
Figure 4 (Image 5)
Figure 5 (Image 6)
Figure 6 (Image 7)
5 mg Container Label (Image 8)
Risedronate is a prescription drug available in a package of 30 film-coated tablets, each containing the equivalent of 5 mg of anhydrous risedronate sodium, USP, in the form of the monohydrate. The usual dosage should be taken as directed by a prescriber, and the full prescribing information is available in the package insert. The medication should be stored at a controlled temperature and protected from light and moisture. The bottle has a child-resistant closure as required by USP, and it is important to keep all medications out of reach of children. This medication was made for Teva Pharmaceuticals and is manufactured in Kfar Saba, 4410202, Israel.*
30 mg Container Label (Image 9)
Risedronate is a prescription medication that comes in the form of a fin-coated tablet containing 30mg of anhydrous risedronate Sodium, USP. It is dispensed by pharmacists using the NDC 0093-3100-56 code and comes with an accompanying Medication Guide for patients. The medication is intended to be taken as directed by the prescriber, with dosage information provided in the package insert. Risedronate should be stored at a controlled room temperature between 20-25°C (68-77°F) and dispensed in a tight, light-resistant container. The medication is manufactured by Teva Pharmaceuticals and should be kept out of reach of children. The text also includes manufacture and serialization coding information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
